Australia markets open in 8 minutes

Marker Therapeutics, Inc. (MRKR)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
4.2000+0.1000 (+2.44%)
At close: 04:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts0000
Avg. Estimate0000
Low estimate0000
High estimate0000
Year ago EPS-1.2-1.1N/AN/A
Revenue estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts1111
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago sales964k790k9.01MN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202229/06/202229/09/202230/12/2022
Est. EPS-1.33-1.27-1.2-1
Actual EPS-1.2-1.1-0.8-0.48
Difference0.130.170.40.52
Surprise %9.80%13.40%33.30%52.00%
EPS trendCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Current estimate0000
7 days ago-0.8-0.8-3.4-1.08
30 days ago-0.8-0.8-3.4-1.08
60 days ago-0.8-0.8-3.4-1.08
90 days ago-0.8-0.8-3.4-1.08
EPS revisionsCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesMRKRIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current yearN/AN/AN/AN/A
Next yearN/AN/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A